CAPIVASERTIB | CAPIVASERTIB | ATC L01EX27
ANTINEOPLASTIC TREATMENT OF BREAST CANCER INHIBITOR OF SERINE/THREONINE KINASE AKT (AKT1, AKT2 AND AKT3) | ORAL | Cmax 3.2 MICROMOLAR Tmax 1.5 HOUR F 29 PERCENT VD 1847 LITER PPB 22 PERCENT Cl 50 LITER / HOUR HT 8.3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE AT PH VALUES ABOVE 6.8 | SERINE THREONINE KINASE AKT1 AKT2 AND AKT3 PDB 4GV1 (PKB ALPHA IN COMPLEX WITH AZD5363) LIGAND CODE = 0XZ (link to the list of PDB complexes) Download experimental 3D coordinates of 0XZ with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |